Biogen Idec International Neuroscience GmbH Files Patent Application for Use of an Anti a Synuclein Antibody to Diagnose an Elevated Level of a Synuclein in the Brain

According to the Controller General of Patents, Designs & Trade Marks, "This disclosure relates to the use of anti-a-synuclein antibody to diagnose an elevated level of a-synuclein in the brain.

Saved in:
Bibliographic Details
Published in:Indian Patents News
Format: Newsletter
Language:English
Published: New Delhi Athena Information Solutions Pvt. Ltd 27.03.2015
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first